Gazi University, School of Medicine, Department of Pediatrics, Ankara, Turkey.
Hôpital Necker-Enfants Malades, Paris, France.
Turk J Haematol. 2012 Sep;29(3):265-9. doi: 10.5505/tjh.2012.62134. Epub 2012 Oct 5.
Familial hemophagocytic lymphohistiocytosis (FHL) is a genetically heterogeneous disease. Presentation of the disease such as primarily fever, hepatosplenomegaly, and cytopenia, which are the results of functional degradation in cytotoxic T-lymphocytes and natural killer cells, activation of macrophages and T-lymphocytes, over production of proinflammatory cytokines, and hemophagocytosis. In all, 5 genetic loci have been identified in FHL, and all known affected genes encode critical components of the granule exocytosis pathway, which is essential for the release of cytotoxic granules and proteases that are necessary for targeted cell death. Herein we present an FHL patient with a severe clinical course and a very rare perforin gene mutation. The patient was homozygous for A665G mutation. However, the child died in a short period of time. Prenatal diagnosis was performed in the family and the fetus was found to be heterozygous for the mutation.
家族性噬血细胞性淋巴组织细胞增生症(FHL)是一种遗传异质性疾病。该病的表现主要为发热、肝脾肿大和血细胞减少,这是细胞毒性 T 淋巴细胞和自然杀伤细胞功能下降、巨噬细胞和 T 淋巴细胞激活、促炎细胞因子过度产生以及噬血细胞作用的结果。总共在 FHL 中已经确定了 5 个遗传位点,所有已知受影响的基因都编码颗粒胞吐途径的关键组成部分,该途径对于释放细胞毒性颗粒和蛋白酶至关重要,这些颗粒和蛋白酶是靶向细胞死亡所必需的。在此,我们介绍了一名 FHL 患者,其临床表现严重,且存在一种非常罕见的穿孔素基因突变。该患者为 A665G 突变的纯合子。然而,患儿在短时间内死亡。对该家族进行了产前诊断,发现胎儿为该突变的杂合子。